Hosted on MSN6d
Piper Sandler Downgrades Amphastar Pharmaceuticals (AMPH)
Fintel reports that on February 4, 2025, Piper Sandler downgraded their outlook for Amphastar Pharmaceuticals (NasdaqGS:AMPH) ...
Piper Sandler cuts Amphastar stock rating, slashes price target
Piper Sandler adjusted its stance on Amphastar Pharmaceuticals (NASDAQ:AMPH), downgrading the company's stock rating from Overweight to Neutral and significantly reducing the price target to $36.00 ...